Nerivio Treatment for TMJ Disorder

This trial explores a new treatment for temporomandibular disorder (TMD), a common cause of jaw and face pain often linked to headaches. The treatment uses a device called Nerivio, which sends small electrical pulses to the arm to reduce pain by activating the body's natural pain control system. The trial seeks participants who have experienced TMD pain for at least 6 months and have significant pain on most days. As an unphased trial, this study offers patients the chance to contribute to innovative research that could lead to new pain management solutions.

You must keep your current TMD treatment the same, including medication type, dosage, and frequency, from 3 months before joining the study until it ends. If you're taking more than one prescription drug for pain, you may not be eligible to participate.

Research has shown that the Nerivio device, which employs Remote Electrical Neuromodulation (REN), is generally safe for treating migraines. In large studies, only 0.5% of users experienced mild side effects. The FDA has approved the device for individuals as young as 8 years old. However, individuals with certain conditions, such as uncontrolled epilepsy or specific implanted medical devices like pacemakers, should not use Nerivio. Overall, evidence suggests that Nerivio is well-tolerated for its intended use.¹²³⁴⁵

Most treatments for TMJ disorder involve medications, physical therapy, or even surgery. But Nerivio offers something different. It's a wearable device that uses remote electrical neuromodulation (REN) to stimulate nerves in the upper arm, triggering the body's natural pain-relief mechanisms without drugs. This method is non-invasive and controlled via a smartphone app, making it convenient for self-administration. Researchers are excited because it could offer a drug-free, user-friendly alternative to traditional treatments.

Research has shown that the Nerivio device can help manage pain through Remote Electrical Neuromodulation (REN). This method activates the body's natural pain control system, which often functions poorly in individuals with jaw disorders and migraines. The FDA has already approved the Nerivio device for treating migraines in people aged 8 and older. In this trial, participants will use the Nerivio device to stimulate the upper arm, potentially reducing pain and symptoms related to jaw disorders. This offers a promising non-drug treatment for jaw pain and headaches.⁶⁷⁸⁹¹⁰